Sphera Funds Management Ltd. Taysha Gene Therapies, Inc. Transaction History
Sphera Funds Management Ltd.
- $382 Million
- Q3 2025
A detailed history of Sphera Funds Management Ltd. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 408,146 shares of TSHA stock, worth $1.72 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
408,146
Previous 420,000
2.82%
Holding current value
$1.72 Million
Previous $970,000
32.47%
% of portfolio
0.34%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding TSHA
# of Institutions
163Shares Held
247MCall Options Held
463KPut Options Held
246K-
Rtw Investments, LP New York, NY24.4MShares$103 Million1.03% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$99.2 Million1.27% of portfolio
-
Avoro Capital Advisors LLC New York, NY21.7MShares$91.4 Million0.93% of portfolio
-
Morgan Stanley New York, NY19.3MShares$81.3 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY13.4MShares$56.3 Million0.01% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $204M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...